Vertex Pharmaceuticals (VRTX) FCF Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -596.00 |
| Dec 31, 2025 | -1,634.00 |
| Sep 30, 2025 | -1,060.00 |
| Jun 30, 2025 | -3,567.00 |
| Mar 31, 2025 | -2,446.00 |
| Dec 31, 2024 | -25,863.00 |
| Sep 30, 2024 | 1,429.00 |
| Jun 30, 2024 | -19,202.00 |
| Mar 31, 2024 | 1,029.00 |
| Dec 31, 2023 | -2,735.00 |
| Sep 30, 2023 | 350.00 |
| Jun 30, 2023 | 428.00 |
| Mar 31, 2023 | 126.00 |
| Dec 31, 2022 | 1,706.00 |
| Sep 30, 2022 | 1,403.00 |
| Jun 30, 2022 | 1,928.00 |
| Mar 31, 2022 | 693.00 |
| Dec 31, 2021 | 1,670.00 |
| Sep 30, 2021 | 3,145.00 |
| Jun 30, 2021 | -1,978.00 |
| Mar 31, 2021 | 5,611.00 |
| Dec 31, 2020 | 2,318.00 |
| Sep 30, 2020 | 7,108.00 |
| Jun 30, 2020 | 14,143.00 |
| Mar 31, 2020 | 23,043.00 |
| Dec 31, 2019 | 41,143.00 |
| Sep 30, 2019 | 10,340.00 |
| Jun 30, 2019 | 16,167.00 |
| Mar 31, 2019 | 19,722.00 |
| Dec 31, 2018 | 3,025.00 |
| Sep 30, 2018 | 6,048.00 |
| Jun 30, 2018 | 3,990.00 |
| Mar 31, 2018 | 5,995.00 |
| Dec 31, 2017 | 2,457.00 |
| Sep 30, 2017 | -59.00 |
| Jun 30, 2017 | 560.00 |
| Mar 31, 2017 | 3,648.00 |
| Dec 31, 2016 | -5,942.00 |
| Sep 30, 2016 | 479.00 |
| Mar 31, 2016 | 25,313.00 |
| Dec 31, 2015 | 27,961.00 |
| Sep 30, 2015 | 71,126.00 |
| Jun 30, 2015 | 30,049.00 |
| Mar 31, 2015 | 71,192.00 |
| Dec 31, 2014 | 18,840.00 |
| Sep 30, 2014 | 3,502.00 |
| Jun 30, 2014 | 52,922.00 |
| Mar 31, 2014 | 63,978.00 |